GOODLUCK NSE filing

Goodluck India Releases Q3 FY26 Earnings Call Transcript, Focuses on Defense Expansion

The RealCase readHigh impact Positive

Goodluck India's Q3 FY26 earnings call transcript reveals plans to expand defense artillery shell capacity to 4 lakh units with a ₹400 crore investment, expecting revenue from Q1 FY27. The company projects ₹900-1,000 crore revenue from defense and aerospace segments. Q3 standalone sales rose 10% to ₹1,031.58 crore. Revenue guidance of 15-20% for FY26 is maintained.

Why it matters

The substantial investment in defense capacity expansion and the projected significant revenue contribution from this segment are material developments that will have a high impact on the company's future performance and investor outlook.

The market read

The company is undergoing significant expansion in the defense sector, which is a strategic growth area. Positive outlook on future revenues and maintained growth guidance contribute to a positive sentiment.

Goodluck India Limited has released the transcript of its Q3 and 9 Months FY25-26 earnings conference call, which was held on February 16, 2026. During the call, the management discussed the company's performance, sector outlook, and future growth strategies.

The company highlighted a strengthening steel and engineering sector in December 2025, with improved pricing stability and business activity. The imposition of a 12% safeguard duty on certain trade products was noted as providing support to domestic producers. Government initiatives, including a significant increase in public capital expenditure to ₹12.2 lakh crore for infrastructure development and a 15% rise in defense allocation to ₹7.85 lakh crore, are expected to drive demand for Goodluck India's products.

A key focus of the discussion was the expansion of the defense and aerospace business. The company is augmenting its artillery shell production capacity from 1.5 lakh to 4 lakh shells per annum, with an investment of approximately ₹400 crores, to be financed by 60% equity and 40% debt. Revenue from this expansion is expected to commence from Q1 FY27, with full contribution from FY28. The aerospace division is also being developed, with revenues expected to reach ₹200 crores by FY28, boasting projected EBITDA margins of 28-32%. The company anticipates a combined revenue of ₹900 crores to ₹1,000 crores from the defense and aerospace segments at full capacity.

Financially, for Q3 FY26 standalone, sales increased by 10% to ₹1,031.58 crores, with EBITDA at 9.7% of sales, amounting to ₹99.72 crores. PAT before exceptional items grew by 8.4% year-on-year to ₹43.47 crores. For the 9 months of FY26, consolidated sales were ₹3,011.82 crores, and PAT was ₹126.47 crores. The company maintained its revenue growth guidance of 15% to 20% for FY26, with expectations of better performance in FY27. The value-added product mix currently stands at 56-60% and is projected to increase to 60-65% in the coming year. The company also reported that its solar tracker tubes business is expected to generate ₹600-650 crores in revenue for the next financial year.

Filing to action

What to do with a filing like this

Goodluck India Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Goodluck India Limited. Read the original for the full detail.

View original filing